Programs & Therapies
Addiction Treatment: Levels of Care Explained
There are six standard levels of addiction treatment, each designed for a different intensity of need. The right starting point depends on how severe withdrawal is, whether other medical or mental-health conditions are present, and how much support the person has at home. This page explains what each level involves, who it is usually for, and what most insurance plans cover.
Medical Detox
3-7 day supervised withdrawal management
Find Medical Detox →Inpatient / Residential
28-90 days of 24/7 care
Find Inpatient / Residential →Outpatient (IOP / PHP)
9-20 hrs/week while living at home
Find Outpatient (IOP / PHP) →Medication-Assisted Treatment
Buprenorphine, methadone, naltrexone
Find Medication-Assisted Treatment →Dual Diagnosis
Co-occurring mental health + SUD
Find Dual Diagnosis →Telehealth
Remote therapy and MAT prescribing
Find Telehealth →How Clinicians Actually Choose the Right Level of Care
The framework that licensed addiction programs use to match patients to the right intensity of treatment is the ASAM Criteria — a structured assessment published by the American Society of Addiction Medicine. It does not begin with "what do you want?" or "how much can you pay?" It begins with six clinical dimensions, each scored 0 to 5, that together determine whether outpatient visits are enough, a residential bed is warranted, or hospital-level medical detox is required to keep the patient safe.
The Six ASAM Dimensions
- Acute intoxication and/or withdrawal potential. Is the person currently intoxicated, and how risky will withdrawal be? Alcohol and benzodiazepine withdrawal can be fatal; opioid withdrawal is acutely miserable but rarely lethal. This dimension most often drives the detox decision.
- Biomedical conditions and complications. Any active medical condition — pregnancy, uncontrolled diabetes, liver disease, cardiac issues, malnutrition — that affects safety or treatment planning.
- Emotional, behavioral, or cognitive conditions. Co-occurring depression, anxiety, PTSD, bipolar, psychosis, or active suicidality. When both a substance-use disorder and a mental-health condition are present, the patient has a "dual diagnosis" and needs integrated treatment.
- Readiness to change. Is the patient actively motivated, ambivalent, or in denial? This doesn't disqualify anyone — motivational interviewing is built precisely for the ambivalent — but it shapes the intervention.
- Relapse, continued use, or continued problem potential. Past treatment history and current patterns. Repeated relapse from outpatient usually signals a need for a more structured level.
- Recovery environment. Does the person have safe housing, employment, supportive relationships — or are they returning to the same circumstances that sustained the addiction?
A clinician totals the scores across these six dimensions and matches the patient to one of six ASAM levels. Not every patient moves up the ladder; many people start at outpatient and never need residential. A smaller number need hospital-level detox for five days, then step down through residential and intensive outpatient over several months.
The Six ASAM Levels
| Level | Name | Typical Intensity | When It Fits |
|---|---|---|---|
| 0.5 | Early intervention | 1–2 sessions | Problem use, no disorder yet |
| 1 | Outpatient | <9 hrs/week | Mild SUD, stable environment |
| 2.1 | Intensive Outpatient (IOP) | 9–19 hrs/week | Moderate SUD, some instability |
| 2.5 | Partial Hospitalization (PHP) | 20+ hrs/week | Step-down from residential |
| 3 | Residential / Inpatient | 24/7, 28–90 days | Severe SUD, unsafe environment |
| 4 | Medically Managed Intensive | Hospital-based | Severe withdrawal, medical complications |
Substance-Specific Considerations
Alcohol. Severe alcohol withdrawal is among the few detox syndromes that can be fatal without medical supervision. Anyone with a history of daily heavy drinking, past seizures, or delirium tremens (DTs) should be evaluated for medically supervised detox (Level 3.7 or 4) before entering any other program.
Opioids. Medication-assisted treatment — buprenorphine (Suboxone), methadone, or extended-release naltrexone (Vivitrol) — is the standard of care for opioid use disorder and approximately halves the risk of death. The idea that a person must "detox off medication" before being in real recovery is not supported by the evidence; staying on buprenorphine or methadone for a year, two years, or indefinitely is a clinically legitimate outcome. Programs that refuse to allow medication are working against the evidence base.
Stimulants (cocaine, meth). There is no FDA-approved medication for stimulant use disorder, so treatment relies on behavioral approaches — contingency management, cognitive-behavioral therapy, the Matrix model. Withdrawal is not medically dangerous in most cases, but the cravings and depression that follow can be severe, and outpatient support during this period is important.
Benzodiazepines. Like alcohol, unsupervised benzodiazepine withdrawal can cause seizures and, in rare cases, death. Tapering should always be medically supervised, often over weeks or months.
How to Start Treatment
There are five reasonable starting points, depending on the situation:
- Call your primary care doctor. Many PCPs now offer buprenorphine prescriptions and can refer you into the appropriate level of care.
- Call your insurance plan. Ask for the "behavioral health" line and request a list of in-network providers offering substance-use treatment. Plans are now legally required (under parity rules) to offer networks comparable to their medical-surgical networks.
- Contact a treatment-center admissions line. Most accredited centers offer free phone assessments that will tell you which level of care fits.
- Use the SAMHSA treatment locator. findtreatment.gov is the authoritative federal directory, searchable by ZIP and insurance.
- Take a self-assessment first. Our 11-question DSM-5 screening is not a diagnosis, but it will give you language to describe what you are experiencing when you talk to a clinician.
Treatment recommendations vary by individual clinical assessment. This page is educational content — not medical advice. Last updated April 2026. Sources: ASAM Criteria (4th edition), SAMHSA TIP 63: Medications for Opioid Use Disorder, NIDA Principles of Drug Addiction Treatment (3rd edition). See our editorial policy.